RecallRadar

Opdualag Device Recalls

View recent opdualag recall notices and find official safety instructions and remedies.

All BrandsOpdualagAppleSamsungGoogleSonyMicrosoftDell
Lot: 033A23B, Expiry: 4/30/2026medium

Opdualag (nivolumab and relatlimab-rmbw) injection, 240 mg and 80 mg/20 mL (12mg and 4mg/mL),Single Dose Vial, RX Only, Bristol-Myers Squibb Company, Princeton, NJ 08543, NDC 0003-7125-11

Lack of Assurance of Sterility.

Lot: 033A23B, Expiry: 4/30/2026
October 21, 2025
1
Active Recalls
0
High Priority
1
Device Types Affected

Own an Opdualag device?

Register your devices and we'll notify you instantly when a new recall is announced.

Register Your Devices
Opdualag Device Recalls | RecallRadar